| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 12/21/2006 | CA2611839A1 Method of treating or preventing benign prostatic hyperplasia using modified pore-forming proteins |
| 12/21/2006 | CA2611836A1 Transmucosal delivery of peptide derivatives |
| 12/21/2006 | CA2611054A1 Novel a.beta.-binding protein and its peptide derivatives and uses thereof |
| 12/21/2006 | CA2611048A1 Psp94 diagnostic reagents and assays |
| 12/21/2006 | CA2611023A1 Use of panton-valentine leukocidin for treating and preventing staphylococcus infections |
| 12/21/2006 | CA2610919A1 Hepatitis c virus nucleic acid vaccine |
| 12/20/2006 | EP1734124A1 Prostate specific antigen peptides and uses thereof |
| 12/20/2006 | EP1734122A2 APO-2 ligand |
| 12/20/2006 | EP1734121A2 Genetically engineered human-derived Kunitz domains that inhibit human neutrophil elastase |
| 12/20/2006 | EP1734120A2 Reagents and methods for identifying and modulating expression of genes regulated by CDK inhibitors |
| 12/20/2006 | EP1734119A2 CD16-II variants |
| 12/20/2006 | EP1734118A1 Identification of JAK/STAT pathway modulating genes by genome wide RNAi screening |
| 12/20/2006 | EP1734117A1 Novel fluorescent protein and gene encoding the same |
| 12/20/2006 | EP1734112A1 Method of proliferating pluripotent stem cell |
| 12/20/2006 | EP1734053A2 Monoclonal antibodies that recognize flk-2 receptors and the isolation of primitive hematopoietic stem cell populations |
| 12/20/2006 | EP1734052A1 Heterodimeric peptide compounds displaying ngf activity and their use to treat neurodegenerative disorders |
| 12/20/2006 | EP1734051A2 Composition and methods for the diagnosis of tumours |
| 12/20/2006 | EP1734050A2 Immunization of dairy cattle with GapC protein against streptococcus infection |
| 12/20/2006 | EP1734049A1 Tumour-associated peptides that bind to MHC-molecules |
| 12/20/2006 | EP1734048A1 Tumor-associated peptides that bind to MHC-molecules |
| 12/20/2006 | EP1733743A1 Preventives/remedies for cancer |
| 12/20/2006 | EP1733738A1 Method of preventing ultraviolet ray-induced apoptosis |
| 12/20/2006 | EP1733237A2 Diagnostics and therapeutics for diseases associated with peroxisome proliferative activated receptor alpha (ppara) |
| 12/20/2006 | EP1733231A2 Peptides and peptidomimetics binding to cd23 |
| 12/20/2006 | EP1733040A2 Filamentous fungal mutants with improved homologous recombination efficiency |
| 12/20/2006 | EP1733039A2 Improved bacterial host cell for the direct expression of peptides |
| 12/20/2006 | EP1733038A2 Method for producing purine nucleosides and nucleotides by fermentation using bacterium belonging to the genus bacillus or escherichia |
| 12/20/2006 | EP1733037A2 Process for producing polypeptides |
| 12/20/2006 | EP1732951A2 Monoclonal antibodies with specificity for fetal erythroid cells |
| 12/20/2006 | EP1732947A2 Growth factor binding constructs materials and methods |
| 12/20/2006 | EP1732946A2 Dimeric fusion proteins and materials and methods for producing them |
| 12/20/2006 | EP1732945A1 Methods and compositions for modulating cardiac contractility |
| 12/20/2006 | EP1732944A1 Monomeric red fluorescent proteins |
| 12/20/2006 | EP1732943A2 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of breast cancer |
| 12/20/2006 | EP1732942A2 Synthetic chemokines, methods of manufacture, and uses |
| 12/20/2006 | EP1732940A2 METHOD FOR CONSTRUCTION AND USE OF <i>KLUYVEROMYCES LACTIS</i> PROMOTER VARIANTS IN <i>K.LACTIS</i> THAT SUBSTANTIALLY LACK <i>E. COLI</i> TRANSCRIPTIONAL CAPABILITY |
| 12/20/2006 | EP1732609A2 Conjugates of hydroxyalkyl starch and a protein |
| 12/20/2006 | EP1732608A2 Folate conjugates and complexes |
| 12/20/2006 | EP1732599A1 Use of emmprin antagonists for the treatment of diseases associated with excessive angiogenesis |
| 12/20/2006 | EP1732598A2 Inducing cellular immune responses to human papillovirus using peptide and nucleid acid compositions |
| 12/20/2006 | EP1732596A2 Therapeutic use of rm1 antigen |
| 12/20/2006 | EP1732595A2 Identification of self and non-self antigens implicated in autoimmune diseases |
| 12/20/2006 | EP1732593A1 Use of epi-hne 1-4 |
| 12/20/2006 | EP1732589A2 Bmp-3 propeptides and related methods |
| 12/20/2006 | EP1732581A2 Polypeptide transduction and fusogenic peptides |
| 12/20/2006 | EP1732576A1 Method for the photostabilisation of phycobiliproteins in an aqueous extract, compositions containing stabilised phycobiliproteins and use of stabilised phycobiliproteins |
| 12/20/2006 | EP1732382A2 Sfec, a sperm flagellar energy carrier protein |
| 12/20/2006 | EP1687421A4 A process for producing exogenous protein in the milk of trangenic mammals and a process for purifying proteins therefrom |
| 12/20/2006 | EP1658309B1 Peptide protein translation inhibitor and the use thereof for protein translation control |
| 12/20/2006 | EP1578949A4 Site specific incorporation of keto amino acids into proteins |
| 12/20/2006 | EP1563298A4 Methods of isolation of active compounds and activated targets |
| 12/20/2006 | EP1481083B1 Detection of nucleic acids |
| 12/20/2006 | EP1442124B1 Polypeptide antigen forming a mimetic structure of the gp41 intermediate state |
| 12/20/2006 | EP1430462A4 Printed materials comprising a support having an oligomer and/or a polymer applied thereon, a method for preparing the same and a method for delivering and/or storing the same |
| 12/20/2006 | EP1409652B1 Immortalized preosteoblasts and method for their production |
| 12/20/2006 | EP1321473B1 Method for preventing a freeze-induced decrease of the activity of a protein |
| 12/20/2006 | EP1317537B1 G-csf analog compositions and methods |
| 12/20/2006 | EP1299537B1 Compounds targeted to cellular locations |
| 12/20/2006 | EP1194164B1 Prion protein peptides and uses thereof |
| 12/20/2006 | EP1147123B1 Novel odorant receptors in drosophila |
| 12/20/2006 | EP1135477B1 Humanized monoclonal integrin antibodies |
| 12/20/2006 | EP1027027B1 Use of amylin, adrenomedullin and analogues thereof for treating cartilage defects |
| 12/20/2006 | EP1023453B1 Tgc method for inducting targeted somatic transgenesis |
| 12/20/2006 | EP0972032B1 Peptides for the treatment of systemic lupus erythematosus |
| 12/20/2006 | EP0964916B1 Hbv mutants and methods for detecting same |
| 12/20/2006 | EP0942983B1 Streptococcus pneumoniae antigens and vaccines |
| 12/20/2006 | EP0839193B1 Porphyrin-accumulating type herbicide resistance gene |
| 12/20/2006 | EP0833660B1 Vectors for the diagnosis and treatment of solid tumors including melanoma |
| 12/20/2006 | CN1882837A Hairless protein-interacting partner complexes and methods thereof for the beautification and/or improvement of mammalian skin |
| 12/20/2006 | CN1882704A A method for detecting nipah virus and method for providing immunoprotection against henipaviruses |
| 12/20/2006 | CN1882690A Nucleic acid and gene originating in novel hcv strain and replicon-replicating cell using the gene |
| 12/20/2006 | CN1882689A Methods for producing olfactory GPCRs |
| 12/20/2006 | CN1882687A Method of growing myocardial cells |
| 12/20/2006 | CN1882685A A process for producing exogenous protein in the milk of trangenic mammals and a process for purifying proteins therefrom |
| 12/20/2006 | CN1882608A Isolated photoprotein mtclytin, and use thereof |
| 12/20/2006 | CN1882605A Improved expression systems using Sec-system secretion |
| 12/20/2006 | CN1882359A Pharmaceutical compositions for therapeutic use |
| 12/20/2006 | CN1882355A Long acting erythropoietins that maintain tissue protective activity of endogenous erythropoietin |
| 12/20/2006 | CN1880457A Ad6重组核酸 Ad6 recombinant nucleic acid |
| 12/20/2006 | CN1880455A Human tumor suppressor gene NECL2 and apoptosis of leukemia cells induced by its interactive protein |
| 12/20/2006 | CN1880453A Nerve differentiation induced gene Ccd1 having high expression in brain |
| 12/20/2006 | CN1880452A Human SEMA 4C gene capable of inhibiting myoblast multiplication and promoting differentiation to myotube |
| 12/20/2006 | CN1880334A High purity albumin production process |
| 12/20/2006 | CN1879877A Tumour-specific animal proteins |
| 12/20/2006 | CN1291022C SCYTALONE dehydrogenase gene showing tolerance to agricultural pesticide |
| 12/20/2006 | CN1291021C Use of boea crassifolia BcBCP1 gene for breeding drought-salt-tolerant plants |
| 12/20/2006 | CN1291019C Novel natural antibacterial peptide HKABF and its preparation and application |
| 12/20/2006 | CN1291010C Production of mammals which produce progeny single sex |
| 12/20/2006 | CN1290863C Preparation and use of antioxidant component from protein liquid of living scorpion |
| 12/20/2006 | CN1290862C Spleen polypeptide extract, its preparing process and use |
| 12/20/2006 | CN1290861C New type human bone marrow stroma cell source 1 type phosphatase inhibition factor, its coded sequence and use |
| 12/20/2006 | CN1290860C DREB transcription factor and its coding gene and use |
| 12/20/2006 | CN1290859C Vectors, constructs, and transgenic plants for hpv-11 and hpv-16 l1 capsid protein |
| 12/20/2006 | CN1290579C Recombinant foot-and-mouth disease virus VP1 confluent protein vaccine |
| 12/20/2006 | CA2549086A1 Chimeric polypeptides and their therapeutic applications against a flaviviridae infection |
| 12/20/2006 | CA2508266A1 Chimeric polypeptides and their therapeutic application against a flaviviridae infection |
| 12/19/2006 | USRE39433 Therapeutic agents as cytokine antagonists and agonists |
| 12/19/2006 | US7151206 Arabidopsis argos, a novel gene involved in organ development |
| 12/19/2006 | US7151205 DNA molecules and the amino acid encoded by the DNA molecules, which are critical to male fertility, a promoter and the essential sequences ofthe DNA is identified and using such DNA molecule to mediate fertility in plants; hybrid |
| 12/19/2006 | US7151203 Transforming a grape plant cell with a nucleic acid molecule which encodes a cecropin B peptide, wherein expression of B peptide,increaes resistance to bunch rot disease caused by botrytis |